Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Oct 14, 2021 9:25pm
Todays House Positions + 110k OTC
House Positions for C:ARCH from 20211014 to 20211014 House Bought $Val Ave Sold $Val Ave Net $Net
...more
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Post by
stocksarefun
on Oct 14, 2021 5:36pm
WHY WE HOLD
the games are going to start. The violent swings up and down, the stop loss triggers, the tricks often used by big money to rid retail of their holdings. It's important to look at the 18 months
...more
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Oct 14, 2021 5:26pm
RE:Why?
The best cure for what you have is more Arch.
(22)
•••
Bertie20
X
View Profile
View Bullboard History
Comment by
Bertie20
on Oct 14, 2021 4:29pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:2.39 ASK
Thanks GoldenArm! I saw your recommendation for Arch on the DME board, checked it out, and went with it. So many thanks for the heads up! The way Arch is going, I can see its share price
...more
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Oct 14, 2021 4:25pm
Told myself i wont drink for a while
But here i am on a thursday afternoon, getting ready to go to the beer store. 7 straight green days does that folks
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Oct 14, 2021 3:53pm
The hardest part will be not selling
We should have been above these prices when the government paid for phase II
(93)
•••
SrPlata
X
View Profile
View Bullboard History
Post by
SrPlata
on Oct 14, 2021 3:52pm
Why?
Why does the Carpenters song from the 70's "We've only Just Begun" alternating with The Jeffersons theme song "movin on up" keep riinging in my head? should I see a
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Oct 14, 2021 3:43pm
RE:RE:RE:RE:AND WE ARE STILL CHEAP
Let's hope the ride continues or they company release the forgone conclusion on the drug which is that it is a winner. GLTA
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Oct 14, 2021 2:51pm
RE:RE:RE:AND WE ARE STILL CHEAP
I will sell 33% at 5$, 33% at 10$ and let the other 33% ride until acquisition or revenue, provided there is no bad news hit.
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Oct 14, 2021 2:42pm
RE:RE:AND WE ARE STILL CHEAP
Very cheap. $5 is even really cheap for this type of drug imo, but i guess you have to take profits somewhere. I think this can have a SAVA type run. $30-$50.
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Oct 14, 2021 2:36pm
RE:AND WE ARE STILL CHEAP
Correct. The wait has been worth it. I'm not selling a share under 5
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Oct 14, 2021 2:36pm
RE:AND WE ARE STILL CHEAP
We are still a bargain stock in my opinion - all longs will be rewarded shortly.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Oct 14, 2021 2:27pm
AND WE ARE STILL CHEAP
This play is held tight
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Oct 14, 2021 2:02pm
RE:RE:RE:RE:RE:RE:RE:RE:2.39 ASK
Hey Bertie DME fizzled and now you are here. Good for you. The bids and asks are rigged for stocks like these. The market makers are in charge. I've bought stock and it never showed up on the
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income